Japan Recommends Approval Of Brukinza, Balversa

Brogidirsen, Iclepertin To Get Sakigake Status

Along with several new positive approval recommendations, Japan's proceeding to grant Sakigake designation to two drugs including a DMD gene therapy discovered through public collaboration. Meanwhile, the PMDA has opened a new full-time office in the US.

(Shutterstock)

More from Pink Sheet

More from Rare Diseases